Page 53 - ARNM-2-3

Advances in Radiotherapy
& Nuclear Medicine Image-guided interventional radiotherapy

doi: 10.1111/den.14317 placement for liver cancer robotic stereotactic radio-surgery
treatment: A comparative analysis of three types of markers
3. Elmunzer BJ, Maranki JL, Gómez V, et al. ACG clinical
guideline: Diagnosis and management of biliary strictures. and needles. Arab J Gastroenterol. 2017;18:83-86.
Am J Gastroenterol. 2023;118:405-426. doi: 10.1016/j.ajg.2017.05.007
doi: 10.14309/ajg.0000000000002190 14. Scher N, Bollet M, Bouilhol G, et al. Safety and efficacy of
fiducial marker implantation for robotic stereotactic body
4. Chung C, Kim Y, Park D. Transthoracic needle biopsy: radiation therapy with fiducial tracking. Radiat Oncol.
How to maximize diagnostic accuracy and minimize 2019;14:167.
complications. Tuberc Respir Dis (Seoul). 2020;83:S17-S24.
doi: 10.1186/s13014-019-1373-2
doi: 10.4046/trd.2020.0156
15. Akasaka H, Mizonobe K, Oki Y, et al. Fiducial marker
5. De Filippo M, Saba L, Silva M, et al. CT-guided biopsy position affects target volume in stereotactic lung irradiation.
of pulmonary nodules: Is pulmonary hemorrhage a J Appl Clin Med Phys. 2022;23:e13596.
complication or an advantage? Diagn Interv Radiol.
2014;20:421-425. doi: 10.1002/acm2.13596
doi: 10.5152/dir.2014.14019 16. Kim JH, Hong SS, Kim JH, et al. Safety and efficacy of ultrasound-
guided fiducial marker implantation for CyberKnife radiation
6. Ji Z, Jiang Y, Guo F, et al. Dosimetry verification of therapy. Korean J Radiol. 2012;13:307-313.
radioactive seed implantation for malignant tumors assisted
by 3D printing individual templates and CT guidance. Appl doi: 10.3348/kjr.2012.13.3.307
Radiat Isot. 2017;124:68-74. 17. Ali ZS, Solomon E, Mann P, Wong S, Chan KKW, Taggar AS.
doi: 10.1016/j.apradiso.2016.12.009 High dose rate brachytherapy in the management of anal
cancer: A review. Radiother Oncol. 2022;171:43-52.
7. Wang H, Ren T, Chen P, et al. Application of 3-dimensionally
printed coplanar template improves diagnostic yield of doi: 10.1016/j.radonc.2022.03.019
CT-guided percutaneous core needle biopsy for pulmonary 18. Strouthos I, Karagiannis E, Zamboglou N, Ferentinos K.
nodules. Technol Cancer Res Treat. 2022;21. High-dose-rate brachytherapy for prostate cancer: Rationale,
doi: 10.1177/15330338221089940 current applications, and clinical outcome. Cancer Rep
(Hoboken). 2022;5:e1450.
8. Haoran E, Chen J, Sun W, et al. Three-dimensionally printed
navigational template: A promising guiding approach for doi: 10.1002/cnr2.1450
lung biopsy. Transl Lung Cancer Res. 2022;11:393-403. 19. Miglierini P, Malhaire JP, Goasduff G, Miranda O,
doi: 10.21037/tlcr-22-172 Pradier O. Cervix cancer brachytherapy: High dose rate.
Cancer Radiother. 2014;18:452-457.
9. Desai R, Rich KM. Therapeutic role of gamma knife
stereotactic radiosurgery in neuro-oncology. Mo Med. doi: 10.1016/j.canrad.2014.06.008
2020;117:33-38. 20. Viswanathan AN, Beriwal S, De Los Santos JF, et al.
10. Spina A, Garbin E, Albano L, Bisoglio A, Boari N, Mortini P. American Brachytherapy Society consensus guidelines for
Gamma Knife radiosurgery for central neurocytoma: locally advanced carcinoma of the cervix. Part II: High-
A quantitative systematic review and metanalysis. Neurosurg dose-rate brachytherapy. Brachytherapy. 2012;11:47-52.
Rev. 2024;47:64. doi: 10.1016/j.brachy.2011.07.002
doi: 10.1007/s10143-024-02301-7 21. Renard S, Salleron J, Py JF, et al. High-dose-rate

11. Nemoto H, Saito M, Suzuki T, et al. Evaluation of computed brachytherapy for facial skin cancer: Outcome and toxicity
tomography metal artifact and CyberKnife fiducial assessment for 71 cases. Brachytherapy. 2021;20:624-630.
recognition for novel size fiducial markers. J Appl Clin Med doi: 10.1016/j.brachy.2021.01.009
Phys. 2023;24:e14142.
22. Itami J, Murakami N, Watanabe M, et al. Combined
doi: 10.1002/acm2.14142 interstitial and intracavitary high-dose rate brachytherapy
12. Suzuki T, Saito M, Onishi H, et al. Comparison of CT artifacts of cervical cancer. Front Oncol. 2021;11:809825.
and image recognition of various fiducial markers including doi: 10.3389/fonc.2021.809825
two types of thinner fiducial markers for CyberKnife 23. Zeng H, Dai J, Cao D, et al. Safety and efficacy associated
treatment. Rep Pract Oncol Radiother. 2020;25:117-124.
with single-fraction high-dose-rate brachytherapy in
doi: 10.1016/j.rpor.2019.12.005 localized prostate cancer: A systematic review and meta-
analysis. Strahlenther Onkol. 2023;199:525-535.
13. Marsico M, Gabbani T, Lunardi S, Galli A, Biagini MR,
Annese V. Percutaneous ultrasound-guided fiducial marker doi: 10.1007/s00066-023-02063-z

Volume 2 Issue 3 (2024) 8 doi: 10.36922/arnm.3781